Speaker:
Navonil De Sarkar, PhD, Medical College of Wisconsin
At the conclusion of this activity, learners should be able to:
* Nucleosome profiles from ctDNA can accurately depict prostate cancer epigenetic subtypes/phenotypic subtypes
* With our approach we can derive AR activity signature from ctDNA
* It is feasible to use AS activity signature as clinical determinant for standard of care antiandrogen therapy responses
* Potential tool for precision medicine for monitoring therapy-induced disease evolution
Current Topics in Pathology 2023